Monitoring early tumor response to drug therapy with diffuse optical tomography
Molly Flexman(Philips (United States)), Andreas H. Hielscher(New York University), Darrell J. Yamashiro(Morgan Stanley Children's Hospital), Sonia L. Hernandez(University of Chicago), Mark A. Borden(University of Colorado Boulder), Tessa Johung(Stanford University), Jeffrey W. Gander(Morgan Stanley Children's Hospital), Jessica J. Kandel(Presbyterian College), Brooke S. Lampl(Columbia University), Ari R. Reichstein(Columbia University), Antai Wang(Columbia University), Jianzhong Huang, Shashank R. Sirsi(University of North Texas at Dallas), Fotios Vlachos(Columbia University), Hyun Keol Kim(Columbia University)
Cited by 30
Related Papers
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711
Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma
|Proceedings of the National Academy of Sciences|2002|313
Regression of established tumors and metastases by potent vascular endothelial growth factor blockade
|Proceedings of the National Academy of Sciences|2003|225
Expression of TrkA, TrkB and TrkC in human neuroblastomas
|Journal of Neuro-Oncology|1997|148
Erratum: Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|136